Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium
elranatamab治疗多发性骨髓瘤的真实世界疗效：来自美国多发性骨髓瘤免疫治疗联盟的多中心分析
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-026-01477-z
Portuguese, Andrew J; Davis, James A; Raza, Shahzad; Castaneda Puglianini, Omar; Freeman, Ciara; Alsina, Melissa; Wright, Corbin; Blue, Brandon J; Baz, Rachid C; Shain, Kenneth H; Goel, Utkarsh; Khouri, Jack; Anwer, Faiz; Ali, Hossam M; Pasvolsky, Oren; Gaballa, Mahmoud; Patel, Krina; Garcia-Pleitez, Hector; Mikulski, Damian; Fogel, Lindsay; Zolotov, Eli; Sannareddy, Aishwarya; Afrough, Aimaz; Anderson, Larry D Jr; Julian, Kelley; Dima, Danai; Banerjee, Rahul; Liang, Emily C; Cassano Cassano, Raffaella; Herr, Megan M; Hassan, Hamza; Shune, Leyla; Kort, Jeries; Midha, Shonali; Nadeem, Omar; Sidana, Surbhi; Lin, Yi; Locke, Frederick L; Hansen, Doris K; Sborov, Douglas; Biran, Noa; Grajales-Cruz, Ariel
